speb/financial-data huggingface dataset:
Financial ratios for CRB.V — annual report dated 2024-02-29
Total revenue: 0
Gross profit: -31028.676470588234
Operating income: -218983.0882352941
Net income: -222469.85294117645
Capital expenditures: 1544.8529411764705
Operating cash flow: -180275
Depreciation & amortization: 31028.676470588234
Net tangible assets: 1129647.794117647
Owner earnings: -192986.0294117647
Return on net tangible assets (%): -17.08373445393248
Buffett classification: The Gruesome
Stock price: 0.03676470588235294
Shares outstanding: 58011888
Book value: 1129647.794117647
P/B ratio: 1.8880132472315356
Market cap (USD): 2132790
Debt to equity: 0.05382013264155082
Current ratio: 1.2272833682119677
Quick ratio: 1.2272833682119677
Interest coverage ratio: -29.058152014830714
Free cash flow (dilution-adjusted): -205655.88235294115
Buyback yield (%): 0
Retained earnings: -1386461.7647058822
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.114309626438626
Rule of 40 score: 0
Financial ratios for CRB.V — quarterly report dated 2024-11-30
Total revenue: 0
Gross profit: -4642.857142857143
Operating income: -30416.428571428572
Net income: -28767.14285714286
Capital expenditures: 87857.14285714287
Operating cash flow: 44158.571428571435
Depreciation & amortization: 4642.857142857143
Net tangible assets: 1140474.2857142857
Owner earnings: -111981.42857142858
Return on net tangible assets (%): -9.81884729661344
Buffett classification: The Gruesome
Stock price: 0.03571428571428572
Shares outstanding: 58011888
Book value: 1140474.285714286
P/B ratio: 1.8166592345039405
Market cap (USD): 2071853.1428571432
Debt to equity: 0.02606747568680699
Current ratio: 4.196911495926396
Quick ratio: 4.196911495926396
Interest coverage ratio: -17.0332
Free cash flow (dilution-adjusted): 44158.571428571435
Buyback yield (%): 0
Retained earnings: -1436754.285714286
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6163046102822496
Rule of 40 score: 0
Financial ratios for CRB.V — annual report dated 2025-02-28
Total revenue: 0
Gross profit: -29305.55555555556
Operating income: -236502.77777777778
Net income: -306570.8333333334
Capital expenditures: 22593.75
Operating cash flow: -167811.80555555556
Depreciation & amortization: 29305.55555555556
Net tangible assets: 1092538.888888889
Owner earnings: -299859.0277777778
Return on net tangible assets (%): -27.44607362056779
Buffett classification: The Gruesome
Stock price: 0.034722222222222224
Shares outstanding: 58011888
Book value: 1092538.8888888888
P/B ratio: 1.8436887575830003
Market cap (USD): 2014301.6666666667
Debt to equity: 0.013978017563575161
Current ratio: 2.4459258780991733
Quick ratio: 2.4459258780991733
Interest coverage ratio: -85.71960734960986
Free cash flow (dilution-adjusted): -213707.6388888889
Buyback yield (%): 0
Retained earnings: -1616006.9444444445
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.647080958216595
Rule of 40 score: 0
Financial ratios for CRB.V — quarterly report dated 2025-02-28
Total revenue: 0
Gross profit: -14027.77777777778
Operating income: -149752.77777777778
Net income: -219162.5
Capital expenditures: 3159.722222222222
Operating cash flow: -60147.222222222226
Depreciation & amortization: 14027.77777777778
Net tangible assets: 1092538.888888889
Owner earnings: -208294.44444444444
Return on net tangible assets (%): -19.065174389927638
Buffett classification: The Gruesome
Stock price: 0.034722222222222224
Shares outstanding: 58011888
Book value: 1092538.8888888888
P/B ratio: 1.8436887575830003
Market cap (USD): 2014301.6666666667
Debt to equity: 0.013978017563575161
Current ratio: 2.4459258780991733
Quick ratio: 2.4459258780991733
Free cash flow (dilution-adjusted): -104643.75
Buyback yield (%): 0
Retained earnings: -1616006.9444444445
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.70686016770316
Rule of 40 score: 0
Financial ratios for CRB.V — quarterly report dated 2025-05-31
Total revenue: 0
Gross profit: -5318.840579710145
Operating income: -24423.188405797104
Net income: -20621.739130434784
Capital expenditures: 152.17391304347828
Operating cash flow: -82523.91304347827
Depreciation & amortization: 5318.840579710145
Net tangible assets: 1122106.5217391306
Owner earnings: -15455.072463768118
Return on net tangible assets (%): -1.3773266765988141
Buffett classification: The Gruesome
Stock price: 0.028985507246376815
Shares outstanding: 58011888
Book value: 1122106.5217391306
P/B ratio: 1.4985243980169285
Market cap (USD): 1681504.0000000002
Debt to equity: 0.004343538647226005
Current ratio: 2.9849997148234757
Quick ratio: 2.9849997148234757
Interest coverage ratio: -44.93866666666667
Free cash flow (dilution-adjusted): -82676.08695652174
Buyback yield (%): 0
Retained earnings: -1706889.8550724639
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.176548120221607
Rule of 40 score: 0
Financial ratios for CRB.V — quarterly report dated 2025-08-31
Total revenue: 0
Gross profit: -4908.759124087591
Operating income: -40890.5109489051
Net income: -37465.69343065693
Capital expenditures: 0
Operating cash flow: -24759.124087591237
Depreciation & amortization: 4908.759124087591
Net tangible assets: 1093513.1386861312
Owner earnings: -32556.93430656934
Return on net tangible assets (%): -2.9772787500008344
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 58011888
Book value: 1093513.1386861315
P/B ratio: 1.9361652959422953
Market cap (USD): 2117222.189781022
Debt to equity: 0
Current ratio: 2.5595539095859077
Quick ratio: 2.5595539095859077
Interest coverage ratio: -224.97991967871482
Free cash flow (dilution-adjusted): -24759.124087591237
Buyback yield (%): 0
Retained earnings: -1756813.8686131386
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.7393707951269355
Rule of 40 score: 0
Financial ratios for CRB.V — quarterly report dated 2025-11-30
Total revenue: 0
Gross profit: 0
Operating income: -62379.28571428572
Net income: -35287.14285714286
Capital expenditures: 0
Operating cash flow: 186607.14285714287
Depreciation & amortization: 0
Net tangible assets: 1036617.8571428572
Owner earnings: -35287.14285714286
Return on net tangible assets (%): -3.4040647297357824
Buffett classification: The Gruesome
Stock price: 0.03571428571428572
Shares outstanding: 58011888
Book value: 1036617.8571428572
P/B ratio: 1.9986662670153283
Market cap (USD): 2071853.1428571432
Debt to equity: 0
Current ratio: 1.5438332525778018
Quick ratio: 1.5438332525778018
Free cash flow (dilution-adjusted): 186607.14285714287
Buyback yield (%): 0
Retained earnings: -1754454.285714286
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.017577768360706
Rule of 40 score: 0
Financial ratios for CRD.AX — annual report dated 2022-12-31
Total revenue: 21.339820742637645
Gross profit: -73.09961587708067
Operating income: -1061.2957106274007
Net income: -1158.2411011523689
Capital expenditures: 4.146927016645327
Depreciation & amortization: 9.361523687580025
Net tangible assets: 2393.324775928297
Owner earnings: -1153.0265044814341
Return on net tangible assets (%): -48.17676715163785
Buffett classification: The Gruesome
Stock price: 0.8716216216216216
Shares outstanding: 194554741
Book value: 2393.3247759282967
P/B ratio: 70854.62054719275
Market cap (USD): 169578118.8445946
Debt to equity: 0.00936302963644642
Current ratio: 3.8936787005515274
Quick ratio: 3.8936787005515274
Interest coverage ratio: -9.81044162684381
COGS to revenue (%): 442.55028080449284
Free cash flow (dilution-adjusted): -648.0436619718309
Buyback yield (%): 0
Retained earnings: -2211.438092189501
Receivables turnover: 1.4027362210523215
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -44.17337279244905
FCF margin (%): -3036.7811884990156
Rule of 40 score: -3036.7811884990156
Financial ratios for CRD.AX — annual report dated 2023-12-31
Operating income: -653.3687520259319
Net income: -630.7076175040519
Capital expenditures: 0.26774716369529983
Depreciation & amortization: 12.612706645056726
Net tangible assets: 2007.4737115072933
Owner earnings: -618.3626580226904
Return on net tangible assets (%): -30.80302643457276
Buffett classification: The Gruesome
Stock price: 0.7876712328767123
Shares outstanding: 194554741
Book value: 2007.4737115072933
P/B ratio: 76337.3247814123
Market cap (USD): 153245172.70547944
Debt to equity: 0.009192294777099074
Current ratio: 1.108402172246374
Quick ratio: 1.108402172246374
Interest coverage ratio: -5620.866146123815
Free cash flow (dilution-adjusted): -922.1179902755267
Buyback yield (%): 0
Retained earnings: -2807.7585089141003
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.41072975084529
Rule of 40 score: 0
Financial ratios for CRD.AX — annual report dated 2024-12-31
Operating income: -494.0342915402596
Net income: -473.2735490127816
Capital expenditures: 0.7311508429900034
Depreciation & amortization: 13.916111304520813
Net tangible assets: 2154.7109215696028
Owner earnings: -460.0885885512508
Return on net tangible assets (%): -21.352682809817406
Buffett classification: The Gruesome
Stock price: 0.5590062111801242
Shares outstanding: 194554741
Book value: 2154.7109215696028
P/B ratio: 50474.19936699254
Market cap (USD): 108757308.63354036
Debt to equity: 0.007452116453698631
Current ratio: 2.5493239596310717
Quick ratio: 2.5493239596310717
Interest coverage ratio: -1181.3346216738516
Free cash flow (dilution-adjusted): -607.9700477445665
Buyback yield (%): 3.8196744798790165e-05
Retained earnings: -2981.77338737753
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.884002952433473
Rule of 40 score: 0
Financial ratios for CRD.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 2154.7109215696028
Buffett classification: The Gruesome
Stock price: 0.5590062111801242
Shares outstanding: 194554741
Book value: 2154.7109215696028
P/B ratio: 50474.19936699254
Market cap (USD): 108757308.63354036
Debt to equity: 0.007452116453698631
Current ratio: 2.5493239596310717
Quick ratio: 2.5493239596310717
Buyback yield (%): 0
Retained earnings: -2981.77338737753
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUOT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.13
Shares outstanding: 31413196
Market cap (USD): 161149695.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUOT — annual report dated 2022-12-31
Total revenue: 15012366
Gross profit: 4748103
Operating income: -6865149
Net income: -6864783
Capital expenditures: 344915
Operating cash flow: -7873307
Depreciation & amortization: 586026
Net tangible assets: 3715530
Owner earnings: -6623672
Return on net tangible assets (%): -178.26991034926377
Buffett classification: The Gruesome
Stock price: 2
Shares outstanding: 31413196
Book value: 4050471
P/B ratio: 15.51088552417731
Market cap (USD): 62826392
Debt to equity: 1.317683301522218
Current ratio: 1.520285917336658
Quick ratio: 1.2025693411823062
Interest coverage ratio: -746.9425524970079
COGS to revenue (%): 68.37205407861758
R&D to revenue (%): 10.998026560237074
SG&A to revenue (%): 66.35987958193932
Free cash flow (dilution-adjusted): -9337386
Buyback yield (%): 0
Retained earnings: -52361834
Inventory turnover: 7.186047635049987
Receivables turnover: 3.905417424885893
Capitalized R&D asset: 1651064
ROCI (R&D-adjusted, %): -56.26874953186163
FCF margin (%): -62.19796399847966
Rule of 40 score: -62.19796399847966
Financial ratios for DUOT — annual report dated 2023-12-31
Total revenue: 7471198
Gross profit: 1308881
Operating income: -11446566
Net income: -11241718
Capital expenditures: 496686
Operating cash flow: -8746564
Depreciation & amortization: 866977
Net tangible assets: 4584536
Owner earnings: -10871427
Return on net tangible assets (%): -237.13254732867188
Buffett classification: The Gruesome
Stock price: 2.9
Shares outstanding: 31413196
Book value: 5366514
P/B ratio: 16.975315521398063
Market cap (USD): 91098268.39999999
Debt to equity: 0.9409797496102684
Current ratio: 1.9269457566599622
Quick ratio: 1.4569303303641794
Interest coverage ratio: -1598.9057130884203
COGS to revenue (%): 82.48097560792795
R&D to revenue (%): 24.26586740172058
SG&A to revenue (%): 146.46240134446978
Free cash flow (dilution-adjusted): -10550520
Buyback yield (%): 0
Retained earnings: -63603552
Inventory turnover: 4.037779008167531
Receivables turnover: 3.550257791970196
Capitalized R&D asset: 2919163.88
ROCI (R&D-adjusted, %): -86.207011270181
Rosenberg metric: -2.083033728553224
FCF margin (%): -141.21590673945462
Revenue growth (%): -50.23304121415638
Rule of 40 score: -191.448947953611
Financial ratios for DUOT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3
Shares outstanding: 31413196
Market cap (USD): 94239588
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUOT — annual report dated 2024-12-31
Total revenue: 7280885
Gross profit: 469215
Operating income: -10983526
Net income: -10764457
Capital expenditures: 1831763
Operating cash flow: -3488687
Depreciation & amortization: 2557299
Net tangible assets: -7861470
Owner earnings: -10038921
Buffett classification: The Gruesome
Stock price: 5.98
Shares outstanding: 31413196
Book value: 2261331
P/B ratio: 83.07094895882116
Market cap (USD): 187850912.08
Debt to equity: 3.7734949018962727
Current ratio: 0.5026366155556962
Quick ratio: 0.4650124807592697
Interest coverage ratio: -38.388635299216396
COGS to revenue (%): 93.55552243992317
R&D to revenue (%): 21.033020024351433
SG&A to revenue (%): 136.26572868545512
Free cash flow (dilution-adjusted): -5438966
Buyback yield (%): 0
Retained earnings: -74368009
Inventory turnover: 11.252337467539762
Receivables turnover: 7.00613924933724
Capitalized R&D asset: 3290918.29
ROCI (R&D-adjusted, %): -50.168124123449665
Rosenberg metric: -0.46314875581303633
FCF margin (%): -74.7019902113548
Revenue growth (%): -2.5472889354558665
Rule of 40 score: -77.24927914681066
Financial ratios for DUOT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.98
Shares outstanding: 31413196
Market cap (USD): 187850912.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUOT — quarterly report dated 2025-03-31
Total revenue: 4952185
Gross profit: 1313659
Operating income: -1789628
Net income: -2079663
Capital expenditures: 572359
Operating cash flow: -4673425
Depreciation & amortization: 879163
Net tangible assets: -4360716
Owner earnings: -1772859
Buffett classification: The Gruesome
Stock price: 5.64
Shares outstanding: 31413196
Book value: 5151954
P/B ratio: 34.388976578595226
Market cap (USD): 177170425.44
Debt to equity: 1.5244697448773805
Current ratio: 0.5344128516881144
Quick ratio: 0.497171773989371
Interest coverage ratio: -5.547909491377252
COGS to revenue (%): 73.47314367294436
R&D to revenue (%): 8.570580460948046
SG&A to revenue (%): 54.09442498614248
Free cash flow (dilution-adjusted): -6250695
Buyback yield (%): 0
Retained earnings: -76447672
Inventory turnover: 6.995524127031735
Receivables turnover: 1.8504934153369232
Capitalized R&D asset: 424431
ROCI (R&D-adjusted, %): -7.333381713948009
FCF margin (%): -126.22095095397283
Rule of 40 score: -126.22095095397283
Financial ratios for DUOT — quarterly report dated 2025-06-30
Total revenue: 5736041
Gross profit: 1518956
Operating income: -3440683
Net income: -3518031
Capital expenditures: 791200
Operating cash flow: -3202312
Depreciation & amortization: 885796
Net tangible assets: -4182980
Owner earnings: -3423435
Buffett classification: The Gruesome
Stock price: 7.15
Shares outstanding: 31413196
Book value: 4732648
P/B ratio: 47.4584949905423
Market cap (USD): 224604351.4
Debt to equity: 1.6604239318030836
Current ratio: 0.36534347030551595
Quick ratio: 0.3263658861399018
Interest coverage ratio: -39.390067430651754
COGS to revenue (%): 73.51908746816838
R&D to revenue (%): 5.3580335287003695
SG&A to revenue (%): 81.10646349982505
Free cash flow (dilution-adjusted): -5147016
Buyback yield (%): 0
Retained earnings: -79965703
Inventory turnover: 8.276405164749544
Receivables turnover: 2.4529978018970398
Capitalized R&D asset: 591707.77
ROCI (R&D-adjusted, %): -18.105824831819913
Rosenberg metric: 0.4836993527805462
FCF margin (%): -89.73115777938129
Revenue growth (%): 15.828487829109777
Rule of 40 score: -73.90266995027152
Financial ratios for DUOT — quarterly report dated 2025-09-30
Total revenue: 6877283
Gross profit: 2516402
Operating income: -1115980
Net income: -1040254
Capital expenditures: 6449998
Operating cash flow: -3156206
Depreciation & amortization: 630716
Net tangible assets: 41051035
Owner earnings: -6859536
Return on net tangible assets (%): -16.709776014173578
Buffett classification: The Gruesome
Stock price: 7.36
Shares outstanding: 31413196
Book value: 49501816
P/B ratio: 4.6705584005241345
Market cap (USD): 231201122.56
Debt to equity: 0.09436320477616417
Current ratio: 3.8518669211033556
Quick ratio: 3.799764834639078
Interest coverage ratio: -38.04390809299789
COGS to revenue (%): 63.40993965203992
R&D to revenue (%): 1.6733352400940895
SG&A to revenue (%): 51.143772911482635
Free cash flow (dilution-adjusted): -10610620
Buyback yield (%): 0
Retained earnings: -81005957
Inventory turnover: 8.656457683237655
Receivables turnover: 2.288938561319695
Capitalized R&D asset: 461059.36
ROCI (R&D-adjusted, %): -2.1179396169231754
Rosenberg metric: 3.2454260604739393
FCF margin (%): -154.2850570494191
Revenue growth (%): 19.89598749381324
Rule of 40 score: -134.38906955560586
Financial ratios for DUOT — quarterly report dated 2025-12-31
Total revenue: 9458142
Gross profit: 2528692
Operating income: -3416587
Net income: -3197083
Capital expenditures: 15849476
Operating cash flow: -2716280
Depreciation & amortization: 251985
Net tangible assets: 48271218
Owner earnings: -18794574
Return on net tangible assets (%): -38.93536309773663
Buffett classification: The Gruesome
Stock price: 11.25
Shares outstanding: 31413196
Book value: 48552566
P/B ratio: 7.278677196999227
Market cap (USD): 353398455
Debt to equity: 0.09551499296659213
Current ratio: 2.0805705553754104
Quick ratio: 2.052916948490797
Interest coverage ratio: -3416587
COGS to revenue (%): 73.26438955980996
R&D to revenue (%): 0
SG&A to revenue (%): 62.85884690671805
Free cash flow (dilution-adjusted): -19538886
Buyback yield (%): 0
Retained earnings: -84203040
Inventory turnover: 22.589231285797645
Receivables turnover: 1.3885498475011102
Capitalized R&D asset: 178525.47000000003
ROCI (R&D-adjusted, %): -6.77662889086732
Rosenberg metric: 0.10679527285366701
FCF margin (%): -206.58270937357463
Revenue growth (%): 37.52730547804998
Rule of 40 score: -169.05540389552465
Financial ratios for DUOT — annual report dated 2025-12-31
Total revenue: 27023651
Gross profit: 7877709
Operating income: -9762878
Net income: -9835031
Capital expenditures: 23663033
Operating cash flow: -13748223
Depreciation & amortization: 2647660
Net tangible assets: 48271218
Owner earnings: -30850404
Return on net tangible assets (%): -63.9105563899382
Buffett classification: The Gruesome
Stock price: 11.25
Shares outstanding: 31413196
Book value: 48552566
P/B ratio: 7.278677196999227
Market cap (USD): 353398455
Debt to equity: 0.09551499296659213
Current ratio: 2.0805705553754104
Quick ratio: 2.052916948490797
Interest coverage ratio: -22.225688144406174
COGS to revenue (%): 70.8488353405689
R&D to revenue (%): 3.1337364444204816
SG&A to revenue (%): 62.14458956711659
Free cash flow (dilution-adjusted): -41547217
Buyback yield (%): 0
Retained earnings: -84203040
Inventory turnover: 62.41362763602698
Receivables turnover: 3.9673422618282985
Capitalized R&D asset: 2471155.13
ROCI (R&D-adjusted, %): -18.82374941808664
Rosenberg metric: 4.8377578539758
FCF margin (%): -153.74390751271915
Revenue growth (%): 271.1588769771807
Rule of 40 score: 117.41496946446154
Financial ratios for ENO.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.806818181818182
Shares outstanding: 84672634
Market cap (USD): 576351224.6136364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENO.MC — annual report dated 2022-12-31
Total revenue: 3609851063.8297873
Gross profit: 1684148936.1702127
Operating income: 31412765.95744681
Net income: 123305319.14893618
Capital expenditures: 81410638.29787235
Operating cash flow: 241355319.14893618
Depreciation & amortization: 66798936.17021277
Net tangible assets: 812806382.9787234
Owner earnings: 108693617.02127661
Return on net tangible assets (%): 13.3726332983438
Capex to operating income (%): 259.16418314819833
Buffett classification: The Gruesome
Stock price: 6.617021276595745
P/E ratio: 4.54384794257465
Shares outstanding: 84672634
Book value: 887398936.1702127
P/B ratio: 0.631374005406669
Market cap (USD): 560280620.7234043
Debt to equity: 1.228426371597605
Current ratio: 1.003817380668703
Quick ratio: 0.9979912687449555
Effective tax rate (%): 27.524515308032043
Interest coverage ratio: 2.0431774148906725
COGS to revenue (%): 53.345750104619164
SG&A to revenue (%): 3.2249518162475024
Free cash flow (dilution-adjusted): 152971276.5957447
Buyback yield (%): 0.47297727281348084
Retained earnings: 109375531.91489363
Inventory turnover: 175.60729530461776
Receivables turnover: 4.079138601947209
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6325790414182342
FCF margin (%): 4.237606313692438
Rule of 40 score: 4.237606313692438
Financial ratios for ENO.MC — annual report dated 2023-12-31
Total revenue: 4214340000
Gross profit: 1943221111.1111112
Operating income: 106536666.66666666
Net income: 130917777.77777778
Capital expenditures: 95006666.66666667
Operating cash flow: 228892222.2222222
Depreciation & amortization: 79102222.22222222
Net tangible assets: 967642222.2222222
Owner earnings: 115013333.33333333
Return on net tangible assets (%): 11.885935802718635
Capex to operating income (%): 89.17743499890493
Buffett classification: The Gruesome
Stock price: 13.200000000000001
P/E ratio: 8.537257412795139
Shares outstanding: 84672634
Book value: 1028398888.8888884
P/B ratio: 1.0868144461023022
Market cap (USD): 1117678768.8000002
Debt to equity: 0.7058026554763125
Current ratio: 1.1415994050926586
Quick ratio: 1.1383612639234828
Effective tax rate (%): 27.90887981915079
Interest coverage ratio: 3.430396050230761
COGS to revenue (%): 53.890262505846444
SG&A to revenue (%): 3.4829231201616913
Free cash flow (dilution-adjusted): 123900000
Buyback yield (%): 0.3863165247751441
Retained earnings: 122286666.66666666
Inventory turnover: 236.35603607770585
Receivables turnover: 3.8402913550297115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.823805711235657
FCF margin (%): 2.9399621293013856
Revenue growth (%): 16.745536740479654
Rule of 40 score: 19.68549886978104
Financial ratios for ENO.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1174923958.3333335
Buffett classification: The Gruesome
Stock price: 14.510416666666666
Shares outstanding: 84672634
Book value: 1215341666.6666665
P/B ratio: 1.0109381034997018
Market cap (USD): 1228635199.6041665
Debt to equity: 0.21876992752381022
Current ratio: 1.0456739043585126
Quick ratio: 1.040575218404851
Buyback yield (%): 0
Retained earnings: 734583333.3333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENO.MC — annual report dated 2024-12-31
Total revenue: 3968856250
Gross profit: 1950745833.3333335
Operating income: -42789583.333333336
Net income: 739923958.3333334
Capital expenditures: 87744791.66666667
Operating cash flow: 98383333.33333334
Depreciation & amortization: 81302083.33333334
Net tangible assets: 1174923958.3333335
Owner earnings: 733481250.0000001
Return on net tangible assets (%): 62.42797627860669
Buffett classification: The Gruesome
Stock price: 14.510416666666666
P/E ratio: 1.6604884674523142
Shares outstanding: 84672634
Book value: 1215341666.6666665
P/B ratio: 1.0109381034997018
Market cap (USD): 1228635199.6041665
Debt to equity: 0.21876992752381022
Current ratio: 1.0456739043585126
Quick ratio: 1.040575218404851
Interest coverage ratio: -1.6741930224975545
COGS to revenue (%): 50.84866494387814
SG&A to revenue (%): 3.7975886209870495
Free cash flow (dilution-adjusted): -2531250
Buyback yield (%): 0.9403218305744544
Retained earnings: 734583333.3333334
Inventory turnover: 175.09136918210572
Receivables turnover: 4.04057219757763
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.8610272618747468
FCF margin (%): -0.06377782012135108
Revenue growth (%): -5.8249631021702095
Rule of 40 score: -5.888740922291561
Financial ratios for ENO.MC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1010958823.5294118
Buffett classification: The Gruesome
Stock price: 25.105882352941176
Shares outstanding: 84672634
Book value: 1058630588.2352943
P/B ratio: 2.0080481438395434
Market cap (USD): 2125781187.717647
Debt to equity: 0.4348459052538462
Current ratio: 0.9680596212188232
Quick ratio: 0.9613829108784606
Buyback yield (%): 0
Retained earnings: 59000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENPH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 182.94
Shares outstanding: 131798220
Market cap (USD): 24111166366.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENPH — annual report dated 2022-12-31
Total revenue: 2330853000
Gross profit: 974595000
Operating income: 450645000
Net income: 397362000
Capital expenditures: 46443000
Operating cash flow: 744817000
Depreciation & amortization: 58775000
Net tangible assets: 512473000
Owner earnings: 409694000
Return on net tangible assets (%): 79.9445043934022
Capex to operating income (%): 10.3058948839996
Buffett classification: The Great
Stock price: 264.96
P/E ratio: 87.8827275159678
Shares outstanding: 131798220
Book value: 825573000
P/B ratio: 42.29941673383214
Market cap (USD): 34921256371.2
Debt to equity: 1.569489312271598
Current ratio: 3.547796289361489
Quick ratio: 3.313224770807513
Effective tax rate (%): 12.097387888011893
Interest coverage ratio: 47.747933884297524
COGS to revenue (%): 58.1871958463275
R&D to revenue (%): 7.243957469647377
SG&A to revenue (%): 15.2349375958072
Free cash flow (dilution-adjusted): 481572000
Buyback yield (%): 0
Retained earnings: 17335000
Inventory turnover: 9.059355545461832
Receivables turnover: 5.286627685440558
Capitalized R&D asset: 168846000
ROCI (R&D-adjusted, %): 21.538395055732384
FCF margin (%): 20.660762390421016
Rule of 40 score: 20.660762390421016
Financial ratios for ENPH — annual report dated 2023-12-31
Total revenue: 2290786000
Gross profit: 1058388000
Operating income: 461425000
Net income: 438936000
Capital expenditures: 110401000
Operating cash flow: 696780000
Depreciation & amortization: 74708000
Net tangible assets: 700526000
Owner earnings: 403243000
Return on net tangible assets (%): 57.56288845810148
Capex to operating income (%): 23.92609849921439
Buffett classification: The Great
Stock price: 132.14
P/E ratio: 39.67734884083329
Shares outstanding: 131798220
Book value: 983624000
P/B ratio: 17.70576642172212
Market cap (USD): 17415816790.8
Debt to equity: 1.3205838816458322
Current ratio: 4.58920572674566
Quick ratio: 4.1880499352989675
Effective tax rate (%): 14.46060424173567
Interest coverage ratio: 52.20330354112456
COGS to revenue (%): 53.79804137095303
R&D to revenue (%): 9.923930039733088
SG&A to revenue (%): 16.13537886122929
Free cash flow (dilution-adjusted): 373522000
Buyback yield (%): 2.354170378139162
Retained earnings: 46273000
Inventory turnover: 5.76978861864744
Receivables turnover: 5.136763693523395
Capitalized R&D asset: 340462820
ROCI (R&D-adjusted, %): 17.445810994200396
Rosenberg metric: 0.49626878931096974
FCF margin (%): 16.30540783818305
Revenue growth (%): -1.7189844232991098
Rule of 40 score: 14.58642341488394
Financial ratios for ENPH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 113.02
Shares outstanding: 131798220
Market cap (USD): 14895834824.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENPH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 68.68
Shares outstanding: 131798220
Market cap (USD): 9051901749.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENPH — annual report dated 2024-12-31
Total revenue: 1330383000
Gross profit: 629138000
Operating income: 90446000
Net income: 102658000
Capital expenditures: 33604000
Operating cash flow: 513693000
Depreciation & amortization: 81389000
Net tangible assets: 579047000
Owner earnings: 150443000
Return on net tangible assets (%): 25.981137973256057
Capex to operating income (%): 37.15366074784954
Buffett classification: The Good
Stock price: 68.68
P/E ratio: 88.17531755537806
Shares outstanding: 131798220
Book value: 833016000
P/B ratio: 10.86642003226829
Market cap (USD): 9051901749.6
Debt to equity: 1.5704320205134115
Current ratio: 3.5253987707755448
Quick ratio: 3.2754271759499827
Effective tax rate (%): 14.564868216280097
Interest coverage ratio: 10.156765861875352
COGS to revenue (%): 52.71000907257534
R&D to revenue (%): 15.132108573245448
SG&A to revenue (%): 25.359388987983163
Free cash flow (dilution-adjusted): 268729000
Buyback yield (%): 4.3235555447483085
Retained earnings: -245206000
Inventory turnover: 4.249866669898911
Receivables turnover: 5.94587238378719
Capitalized R&D asset: 409349300
ROCI (R&D-adjusted, %): 3.0876079323689534
Rosenberg metric: -1.8881743322658973
FCF margin (%): 20.19937115853104
Revenue growth (%): -41.92460579032699
Rule of 40 score: -21.725234631795953
Financial ratios for ENPH — quarterly report dated 2025-03-31
Total revenue: 356084000
Gross profit: 168241000
Operating income: 35084000
Net income: 29730000
Capital expenditures: 14608000
Operating cash flow: 48414000
Depreciation & amortization: 19915000
Net tangible assets: 560931000
Owner earnings: 35037000
Return on net tangible assets (%): 6.2462227974563715
Capex to operating income (%): 41.637213544635735
Buffett classification: The Good
Stock price: 62.05
P/E ratio: 68.76958922805247
Shares outstanding: 131798220
Book value: 810698000
P/B ratio: 10.087701648456022
Market cap (USD): 8178079551
Debt to equity: 1.4901294933501747
Current ratio: 1.8953384358861336
Quick ratio: 1.77110280525391
Effective tax rate (%): 36.60034546734054
Interest coverage ratio: 17.139228138739618
COGS to revenue (%): 52.75244043540288
R&D to revenue (%): 14.090495501061548
SG&A to revenue (%): 23.304332685546107
Free cash flow (dilution-adjusted): -21827000
Buyback yield (%): 1.2223407632147159
Retained earnings: -315856000
Inventory turnover: 1.3042388474223225
Receivables turnover: 1.5782116343490304
Capitalized R&D asset: 50174000
ROCI (R&D-adjusted, %): 3.4318642250354823
FCF margin (%): -6.129733433684187
Rule of 40 score: -6.129733433684187
Financial ratios for ENPH — quarterly report dated 2025-06-30
Total revenue: 363153000
Gross profit: 170493000
Operating income: 40329000
Net income: 37052000
Capital expenditures: 8259000
Operating cash flow: 26629000
Depreciation & amortization: 20085000
Net tangible assets: 633367000
Owner earnings: 48878000
Return on net tangible assets (%): 7.717168718925994
Capex to operating income (%): 20.4790597336904
Buffett classification: The Great
Stock price: 39.65
P/E ratio: 78.25161604923483
Shares outstanding: 131798220
Book value: 880637000
P/B ratio: 5.934112946651117
Market cap (USD): 5225799423
Debt to equity: 1.3726404863752033
Current ratio: 1.9688307733859516
Quick ratio: 1.8200111991426033
Effective tax rate (%): 12.209453856178177
Interest coverage ratio: 49.48343558282209
COGS to revenue (%): 53.05201939678318
R&D to revenue (%): 12.5074004620642
SG&A to revenue (%): 23.33534350535449
Free cash flow (dilution-adjusted): -35526000
Buyback yield (%): 0.5739408953966659
Retained earnings: -309221000
Inventory turnover: 1.113538632265224
Receivables turnover: 1.6268983684111495
Capitalized R&D asset: 79037580
ROCI (R&D-adjusted, %): 2.5717847233343343
Rosenberg metric: 0.04488380436082433
FCF margin (%): -9.782653592287547
Revenue growth (%): 1.985205737971939
Rule of 40 score: -7.797447854315608
Financial ratios for ENPH — quarterly report dated 2025-09-30
Total revenue: 410427000
Gross profit: 196239000
Operating income: 67446000
Net income: 66638000
Capital expenditures: 8032000
Operating cash flow: 13918000
Depreciation & amortization: 20218000
Net tangible assets: 753284000
Owner earnings: 78824000
Return on net tangible assets (%): 10.464048088104885
Capex to operating income (%): 11.90878628828989
Buffett classification: The Great
Stock price: 35.39
P/E ratio: 34.959818661370115
Shares outstanding: 131798220
Book value: 995022000
P/B ratio: 4.6876742482075775
Market cap (USD): 4664339005.8
Debt to equity: 1.2154113175387078
Current ratio: 2.0422655113290937
Quick ratio: 1.8811819895760042
Effective tax rate (%): 13.478492320076866
Interest coverage ratio: 81.26024096385542
COGS to revenue (%): 52.18662514893027
R&D to revenue (%): 11.516298878972387
SG&A to revenue (%): 19.863946572715733
Free cash flow (dilution-adjusted): -45583000
Buyback yield (%): 0
Retained earnings: -242583000
Inventory turnover: 1.1353603460339674
Receivables turnover: 1.5457887184431647
Capitalized R&D asset: 94255490
ROCI (R&D-adjusted, %): 2.990358438112618
Rosenberg metric: 0.5668303207767332
FCF margin (%): -11.106238137354511
Revenue growth (%): 13.017653716202263
Rule of 40 score: 1.9114155788477518
Financial ratios for ENPH — quarterly report dated 2025-12-31
Total revenue: 343321000
Gross profit: 152031000
Operating income: 21798000
Net income: 38713000
Capital expenditures: 9740000
Operating cash flow: 47579000
Depreciation & amortization: 20427000
Net tangible assets: 849975000
Owner earnings: 49400000
Return on net tangible assets (%): 5.8119356451660344
Capex to operating income (%): 44.68299844022388
Buffett classification: The Good
Stock price: 32.05
P/E ratio: 24.53993685696525
Shares outstanding: 131798220
Book value: 1087023000
P/B ratio: 3.885964649322047
Market cap (USD): 4224132950.9999995
Debt to equity: 1.1155127352411127
Current ratio: 2.0654121934793803
Quick ratio: 1.8371928851562809
Effective tax rate (%): -0.041346874434710704
Interest coverage ratio: 26.294330518697226
COGS to revenue (%): 55.71753548428438
R&D to revenue (%): 13.460871895398185
SG&A to revenue (%): 24.472432504856968
Free cash flow (dilution-adjusted): -15253000
Buyback yield (%): 0
Retained earnings: -203896000
Inventory turnover: 0.6640930125986384
Receivables turnover: 1.4934727097933278
Capitalized R&D asset: 92871150
ROCI (R&D-adjusted, %): 0.9276455749315771
Rosenberg metric: -0.9353023314856345
FCF margin (%): -4.442780954267289
Revenue growth (%): -16.350288845519422
Rule of 40 score: -20.79306979978671
Financial ratios for ENPH — annual report dated 2025-12-31
Total revenue: 1472985000
Gross profit: 687004000
Operating income: 164657000
Net income: 172133000
Capital expenditures: 40639000
Operating cash flow: 136540000
Depreciation & amortization: 80645000
Net tangible assets: 849975000
Owner earnings: 212139000
Return on net tangible assets (%): 24.958263478337596
Capex to operating income (%): 24.681003540693684
Buffett classification: The Great
Stock price: 32.05
P/E ratio: 24.53993685696525
Shares outstanding: 131798220
Book value: 1087023000
P/B ratio: 3.885964649322047
Market cap (USD): 4224132950.9999995
Debt to equity: 1.1155127352411127
Current ratio: 2.0654121934793803
Quick ratio: 1.8371928851562809
Effective tax rate (%): 15.956428759752752
Interest coverage ratio: 36.42048219420482
COGS to revenue (%): 53.35974229201248
R&D to revenue (%): 12.836179594496889
SG&A to revenue (%): 22.625620763280004
Free cash flow (dilution-adjusted): -118189000
Buyback yield (%): 3.0765366882980008
Retained earnings: -203896000
Inventory turnover: 2.7286553930434962
Receivables turnover: 6.407597844101948
Capitalized R&D asset: 398976930
ROCI (R&D-adjusted, %): 5.585365224200726
Rosenberg metric: 0.2874400814643718
FCF margin (%): -8.023774851746623
Revenue growth (%): 10.71886817555546
Rule of 40 score: 2.6950933238088375
Financial ratios for EYE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.99
Shares outstanding: 80116665
Market cap (USD): 3844798753.3500004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EYE — annual report dated 2022-12-31
Total revenue: 1644675000
Gross profit: 977010000
Operating income: 58265000
Net income: 42122000
Capital expenditures: 113547000
Operating cash flow: 119198000
Depreciation & amortization: 105968000
Net tangible assets: -151716000
Owner earnings: 34543000
Return on net tangible assets (%): -22.768198476100082
Capex to operating income (%): 194.8802883377671
Buffett classification: The Gruesome
Stock price: 38.76
P/E ratio: 73.72209143440482
Shares outstanding: 80116665
Book value: 901113000
P/B ratio: 3.4460960339047375
Market cap (USD): 3105321935.3999996
Debt to equity: 1.1128693071790108
Current ratio: 1.3763739455766504
Quick ratio: 1.0186310505890828
Effective tax rate (%): 29.72048026919547
Interest coverage ratio: 126.11471861471861
COGS to revenue (%): 40.59555839299558
SG&A to revenue (%): 50.62453068235365
Free cash flow (dilution-adjusted): -7861000
Buyback yield (%): 2.7175282226939186
Retained earnings: 320517000
Inventory turnover: 5.421206904951363
Receivables turnover: 20.586228909027188
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9925803114769423
FCF margin (%): -0.4779667715506103
Rule of 40 score: -0.4779667715506103
Financial ratios for EYE — annual report dated 2023-12-31
Total revenue: 1756371000
Gross profit: 1021716000
Operating income: 27189000
Net income: -65901000
Capital expenditures: 114774000
Operating cash flow: 173033000
Depreciation & amortization: 101422000
Net tangible assets: -148846000
Owner earnings: -79253000
Capex to operating income (%): 422.1339512302769
Buffett classification: The Gruesome
Stock price: 20.93
Shares outstanding: 80116665
Book value: 829418000
P/B ratio: 2.021708955496505
Market cap (USD): 1676841798.45
Debt to equity: 1.1130153915154963
Current ratio: 0.9974101081216997
Quick ratio: 0.695906462157405
Effective tax rate (%): 62.87688442211056
Interest coverage ratio: 1.8961573331473602
COGS to revenue (%): 41.82800786394218
SG&A to revenue (%): 51.51286374006403
Free cash flow (dilution-adjusted): 38085000
Buyback yield (%): 1.6945546101168039
Retained earnings: 254616000
Inventory turnover: 6.126822230376622
Receivables turnover: 20.222108365763233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5319377668946157
FCF margin (%): 2.1683915300355108
Revenue growth (%): 6.79137215559305
Rule of 40 score: 8.95976368562856
Financial ratios for EYE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.91
Shares outstanding: 80116665
Market cap (USD): 874072815.15
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EYE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.42
Shares outstanding: 80116665
Market cap (USD): 834815649.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EYE — annual report dated 2024-12-31
Total revenue: 1823320000
Gross profit: 1059264000
Operating income: 29492000
Net income: -28499000
Capital expenditures: 95505000
Operating cash flow: 133649000
Depreciation & amortization: 99082000
Net tangible assets: -130788000
Owner earnings: -24922000
Capex to operating income (%): 323.8335819883358
Buffett classification: The Gruesome
Stock price: 10.42
Shares outstanding: 80116665
Book value: 816333000
P/B ratio: 1.0226410659620522
Market cap (USD): 834815649.3
Debt to equity: 0.9996300529318305
Current ratio: 0.5335081597526234
Quick ratio: 0.3329460956619415
Interest coverage ratio: 1.8222936233316855
COGS to revenue (%): 41.90465743807999
SG&A to revenue (%): 51.473356295110015
Free cash flow (dilution-adjusted): 21436000
Buyback yield (%): 0.3703811736869893
Retained earnings: 226117000
Inventory turnover: 8.135352115675376
Receivables turnover: 36.51167447635068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9156906444117785
FCF margin (%): 1.1756575916460084
Revenue growth (%): 3.8117800851870136
Rule of 40 score: 4.9874376768330215
Financial ratios for EYE — quarterly report dated 2025-03-31
Total revenue: 510324000
Gross profit: 305134000
Operating income: 26639000
Net income: 14186000
Capital expenditures: 20225000
Operating cash flow: 32239000
Depreciation & amortization: 25120000
Net tangible assets: -110779000
Owner earnings: 19081000
Return on net tangible assets (%): -17.224383682827973
Capex to operating income (%): 75.92251961409963
Buffett classification: The Gruesome
Stock price: 12.78
P/E ratio: 18.044039523121384
Shares outstanding: 80116665
Book value: 836160000
P/B ratio: 1.2245156174655567
Market cap (USD): 1023890978.6999999
Debt to equity: 0.9628695464982778
Current ratio: 0.5427576146549938
Quick ratio: 0.35358782082360657
Effective tax rate (%): 34.21748203106886
Interest coverage ratio: 5.82655293088364
COGS to revenue (%): 40.20778956114155
SG&A to revenue (%): 50.07250295890454
Free cash flow (dilution-adjusted): 4985000
Buyback yield (%): 0.15861063665801006
Retained earnings: 240303000
Inventory turnover: 2.316672500028226
Receivables turnover: 9.598149297522992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7274014147844914
FCF margin (%): 0.9768304057814252
Rule of 40 score: 0.9768304057814252
Financial ratios for EYE — quarterly report dated 2025-06-30
Total revenue: 486423000
Gross profit: 286052000
Operating income: 16449000
Net income: 8725000
Capital expenditures: 11850000
Operating cash flow: 54261000
Depreciation & amortization: 22536000
Net tangible assets: -96176000
Owner earnings: 19411000
Return on net tangible assets (%): -20.182789885210447
Capex to operating income (%): 72.04085354732811
Buffett classification: The Good
Stock price: 23.01
P/E ratio: 80.46285459604557
Shares outstanding: 80116665
Book value: 850581000
P/B ratio: 2.167323819424605
Market cap (USD): 1843484461.65
Debt to equity: 0.8457066405198329
Current ratio: 0.5205094609392559
Quick ratio: 0.30616670571864407
Effective tax rate (%): 28.711496037257945
Interest coverage ratio: 3.907125890736342
COGS to revenue (%): 41.63618907823026
SG&A to revenue (%): 50.81318112013618
Free cash flow (dilution-adjusted): 37105000
Buyback yield (%): 0.0029834805307104445
Retained earnings: 249028000
Inventory turnover: 2.2591468855970014
Receivables turnover: 10.584076765742635
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0611532372624841
FCF margin (%): 7.628134360422924
Revenue growth (%): -4.683495191290239
Rule of 40 score: 2.9446391691326843
Financial ratios for EYE — quarterly report dated 2025-09-30
Total revenue: 487330000
Gross profit: 284131000
Operating income: 9608000
Net income: 3372000
Capital expenditures: 16366000
Operating cash flow: 46634000
Depreciation & amortization: 22185000
Net tangible assets: -90152000
Owner earnings: 9191000
Return on net tangible assets (%): -10.195003993255835
Capex to operating income (%): 170.33721898417986
Buffett classification: The Gruesome
Stock price: 29.19
P/E ratio: 88.9778735817829
Shares outstanding: 80116665
Book value: 858761000
P/B ratio: 2.723232018396271
Market cap (USD): 2338605451.35
Debt to equity: 0.8076379807653119
Current ratio: 0.528073099660643
Quick ratio: 0.3169954312712098
Effective tax rate (%): 38.56804518127163
Interest coverage ratio: 2.332605001213887
COGS to revenue (%): 41.69638643219174
SG&A to revenue (%): 51.779902735312824
Free cash flow (dilution-adjusted): 24767000
Buyback yield (%): 0.03745822107334583
Retained earnings: 252400000
Inventory turnover: 2.3087647139026495
Receivables turnover: 10.563358910998396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6232861738545462
FCF margin (%): 5.082182504668294
Revenue growth (%): 0.18646322233940418
Rule of 40 score: 5.268645727007699
Financial ratios for EYE — quarterly report dated 2025-12-31
Total revenue: 503411000
Gross profit: 292702000
Operating income: 8124000
Net income: 3317000
Capital expenditures: 24399000
Operating cash flow: 13159000
Depreciation & amortization: 32209000
Net tangible assets: -79210000
Owner earnings: 11127000
Return on net tangible assets (%): -14.047468753945209
Capex to operating income (%): 300.33234859675036
Buffett classification: The Gruesome
Stock price: 25.82
P/E ratio: 69.88555034797298
Shares outstanding: 80116665
Book value: 869533000
P/B ratio: 2.3789922755088075
Market cap (USD): 2068612290.3
Debt to equity: 0.7988195962660417
Current ratio: 0.5473269189734438
Quick ratio: 0.33075013093829414
Effective tax rate (%): -38.902847571189284
Interest coverage ratio: 1.912879679773958
COGS to revenue (%): 41.856256617356394
SG&A to revenue (%): 51.88861586258544
Free cash flow (dilution-adjusted): -17090000
Buyback yield (%): 0.031422031235526206
Retained earnings: 255717000
Inventory turnover: 2.3590877538682014
Receivables turnover: 8.782160427061163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5170339916118809
FCF margin (%): -3.3948403987993903
Revenue growth (%): 3.299817372211848
Rule of 40 score: -0.09502302658754225
Financial ratios for EYE — annual report dated 2025-12-31
Total revenue: 1987488000
Gross profit: 1168019000
Operating income: 60820000
Net income: 29600000
Capital expenditures: 72840000
Operating cash flow: 146293000
Depreciation & amortization: 99893000
Net tangible assets: -79210000
Owner earnings: 56653000
Return on net tangible assets (%): -71.52253503345537
Capex to operating income (%): 119.76323577770471
Buffett classification: The Gruesome
Stock price: 25.82
P/E ratio: 69.88555034797298
Shares outstanding: 80116665
Book value: 869533000
P/B ratio: 2.3789922755088075
Market cap (USD): 2068612290.3
Debt to equity: 0.7988195962660417
Current ratio: 0.5473269189734438
Quick ratio: 0.33075013093829414
Effective tax rate (%): 28.984429356301433
Interest coverage ratio: 3.5467693025425704
COGS to revenue (%): 41.23139359835128
SG&A to revenue (%): 51.132434510296406
Free cash flow (dilution-adjusted): 49767000
Buyback yield (%): 0.15493478478440229
Retained earnings: 255717000
Inventory turnover: 9.174735215745986
Receivables turnover: 34.67234220718049
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8707542306541844
FCF margin (%): 2.5040151185818478
Revenue growth (%): 9.003795274554111
Rule of 40 score: 11.507810393135959
Financial ratios for FAN.L — annual report dated 2021-07-31
Total revenue: 378594444.4444445
Gross profit: 182845833.33333334
Operating income: 53823611.11111111
Net income: 28938888.88888889
Capital expenditures: 4772222.222222222
Operating cash flow: 72863888.8888889
Depreciation & amortization: 34827777.777777776
Net tangible assets: -52490277.777777776
Owner earnings: 58994444.44444445
Return on net tangible assets (%): -112.39118355250974
Capex to operating income (%): 8.866410342425102
Buffett classification: The Great
Stock price: 0.059861111111111115
P/E ratio: 0.4096501245776541
Shares outstanding: 198038747
Book value: 257347222.22222227
P/B ratio: 0.04606546492363322
Market cap (USD): 11854819.438472223
Debt to equity: 0.5845809271952075
Current ratio: 1.5507118541284783
Quick ratio: 0.9309094918477886
Effective tax rate (%): 30.625291336485315
Interest coverage ratio: 15.626209677419356
COGS to revenue (%): 51.7040368614906
R&D to revenue (%): 1.646073928419446
SG&A to revenue (%): 24.707250502589986
Free cash flow (dilution-adjusted): 63594444.44444445
Buyback yield (%): 24.66179368049395
Retained earnings: 103691666.66666667
Inventory turnover: 3.133997465033021
Receivables turnover: 6.309615295588167
Capitalized R&D asset: 6231944.444444445
ROCI (R&D-adjusted, %): 13.21387006338243
FCF margin (%): 16.79751126241801
Rule of 40 score: 16.79751126241801